Showing results (371-380 of 3,032) with videos related to

Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Effect of severe renal impairment on the pharmacokinetics and tolerability of the parenteral endothelin antagonist tezosentanP L M van Giersbergen, J Dingemanse
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Receptor assay based on surface plasmon resonance for the assessment of the complex formation activity of cyclosporin A and its metabolitesB Vollenbroeker, M Fobker, B Specht, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patientsL A Calò, L Stanic, P A Davis, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Pharmacokinetics of lithium in healthy volunteers after exposure to high altitudeA Arancibia, C Paulos, J Chávez, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Trends in prescribing proton pump inhibitors in Taiwan: 1997 - 2000T J Chen, L F Chou, S J Hwang
International Journal of Clinical Pharmacology and Therapeutics|May 15, 2012
Drug usage by outpatients in Croatia during an 8-year period: Influence of changes in pricing policyDinko Vitezic, Tomislav Madjarevic, Monja Gantumur, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 15, 2012
Polymorphisms of STAT6 and specific serum IgE levels in patients with penicillin allergyChen-Zheng Huang, Dan Zou, Jing Yang, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 2012
Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009)Yu-Tao Xiang, Julie Kreyenbuhl, Faith B Dickerson, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 2012
Evaluation of intravenous midazolam limited sampling models to determine area under the concentration time curve during cytochrome P450 3A baseline, inhibition and induction or activationAnh N Nguyen, Justin T Hoffman, Shirley M Tsunoda, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 2012
The pharmacokinetics and pharmacodynamics of PF-00734200, a DPP-IV inhibitor, in healthy Japanese subjectsChieko Muto, Haiqing Dai, John G Teeter, et al.
Pageof 304